Achilles Therapeutics to Present at the American Association for Cancer Research (AACR) Annual Meeting 2021
10 mars 2021 17h00 HE
|
Achilles Therapeutics
Achilles Therapeutics to Present at the American Association for Cancer Research (AACR) Annual Meeting 2021 London, UK 10 March 2021 – Achilles Therapeutics plc (“Achilles” or the “Company”), a...
Achilles Therapeutics Announces Filing of Registration Statement for Proposed Initial Public Offering in the United States
01 mars 2021 18h26 HE
|
Achilles Therapeutics
Achilles Therapeutics Announces Filing of Registration Statement for Proposed Initial Public Offering in the United States London, UK 1 March 2021 – Achilles Therapeutics plc (“Achilles” or the...
Achilles Therapeutics Announces Independent Data and Safety Monitoring Committee Review with a Positive Recommendation to Continue with Current Study Design of the Phase I/IIa CHIRON and THETIS Trials
05 févr. 2021 02h00 HE
|
Achilles Therapeutics
Achilles Therapeutics Announces Independent Data and Safety Monitoring Committee Review with a Positive Recommendation to Continue with Current Study Design of the Phase I/IIa CHIRON and THETIS Trials...
Achilles Therapeutics Announces Additional Financing Plans
05 févr. 2021 01h00 HE
|
Achilles Therapeutics
Achilles Therapeutics Announces Additional Financing Plans London, UK 5 February 2021 – Achilles Therapeutics (“Achilles” or the “Company”), today announced that it expects to consider additional...
Achilles Therapeutics Appoints Arjan Roozen as VP, Site Head and General Manager
08 janv. 2021 07h00 HE
|
Achilles Therapeutics
Achilles Therapeutics Appoints Arjan Roozen as VP, Site Head and General Manager London, UK 7 January 2021 – Achilles Therapeutics (“Achilles” or the “Company”), a clinical-stage biopharmaceutical...
Achilles Therapeutics Appoints Lee M. Stern as VP, IR & External Communications
07 déc. 2020 02h00 HE
|
Achilles Therapeutics
Achilles Therapeutics Appoints Lee M. Stern as VP, IR & External Communications Stevenage, UK 7 December 2020 – Achilles Therapeutics (“Achilles”), a clinical-stage biopharmaceutical company...
Achilles Therapeutics Appoints Robert Coutts as Chief Financial Officer
01 déc. 2020 07h00 HE
|
Achilles Therapeutics
Achilles Therapeutics Appoints Robert Coutts as Chief Financial Officer Stevenage, UK 1 December 2020 – Achilles Therapeutics (“Achilles”), a clinical-stage biopharmaceutical company developing...
Achilles Therapeutics Appoints Robert Coutts as Chief Financial Officer
01 déc. 2020 02h00 HE
|
Achilles Therapeutics
Achilles Therapeutics Appoints Robert Coutts as Chief Financial Officer Stevenage, UK 1 December 2020 – Achilles Therapeutics (“Achilles”), a clinical-stage biopharmaceutical company developing...
Achilles Therapeutics Raises £52.7 Million in an Oversubscribed Series C Financing to Further Advance the Development of Personalised T cell Therapies to Treat Solid Tumours
19 nov. 2020 07h00 HE
|
Achilles Therapeutics
Achilles Therapeutics Raises £52.7 Million in an Oversubscribed Series C Financing to Further Advance the Development of Personalised T cell Therapies to Treat Solid Tumours - Financing includes...
Achilles Therapeutics Raises £52.7 Million in an Oversubscribed Series C Financing to Further Advance the Development of Personalised T cell Therapies to Treat Solid Tumours
19 nov. 2020 02h00 HE
|
Achilles Therapeutics
Achilles Therapeutics Raises £52.7 Million in an Oversubscribed Series C Financing to Further Advance the Development of Personalised T cell Therapies to Treat Solid Tumours - Financing includes...